Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination. Wall EC, Wu M, Harvey R, Kelly G, et al. Lancet 2021 Jun 3. pii: S0140-6736(21)01290.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wall EC, Wu M, Harvey R, Kelly G, et al. Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination. Lancet 2021 Jun 3. pii: S0140-6736(21)01290.
PMID: 34090624